Engineered cell therapy for cancer gets thumbs up from FDA advisers – Nature.com
Nature.com |
Engineered cell therapy for cancer gets thumbs up from FDA advisers
Nature.com This is in stark contrast to some other CAR-T trials that have, over the past year, reported the death of several patients from severe brain swelling. Novartis' therapy is not identical to the CAR–T cells used in those trials, which were administered … |
